CliniRx is a full service mid-size CRO that provides comprehensive end- to- end solutions for clinical studies. CliniRx’s services include Phase II –III and late Phase (Phase IV) across numerous therapeutic areas and specialties.These specialty areas include advanced therapies, geriatric population, pediatrics, and rare disease/orphan disease indications. CliniRx offers it’s services to Pharmaceutical, Biotechnology, and Medical Device companies. CliniRx’s rich talent available in-house is supplemented by independent external advisors, who can add value to our work. This is why, we have a network of external advisors and preferred partners. CliniRx conducts clinical trials in USA, Europe and Asia with offices located in India and USA. CliniRx is an affiliate of JK Organisation(www.jkorg.in), an over 125-years-old business conglomerate with leadership across multiple sectors and offices in 88 countries, many of which are public companies. The JK organisation is headquartered in India and has annual revenues of over $4.0 billion. CliniRx derives its values, financial stability and global mindset from JK Organisation enabling CliniRx to rapidly scale up to provide multiple services to Sponsor. CliniRx offers ICH-GCP compliant clinical trial services from Phase II – IV in key therapeutic areas. Multi-site investigator networks next to CliniRx’s well trained in-house team, seamlessly blends into a unique customized solution to match the needs and expectations of small, medium-size and large pharmaceutical, biotechnology and medical device sponsors.
Web: http://clinirx.com
Add：960 Holmdel Road, Suite 2-02,Holmdel, NJ 07733
想要下载更多资料，请您添加微信了解详情！
微信号：csco2022
公众号：康安医药咨询
